Amniotic fluid soluble Toll-like receptor 2 in pregnancies complicated by preterm prelabor rupture of membranes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 5, 2013, Pages 520-527

  Andrys, Ctirad ^a   Kacerovsky, Marian ^a   Drahosova, Marcela ^a   Musilova, Ivana ^a,b   Pliskova, Lenka ^a   Hornychova, Helena ^a   Prochazka, Martin ^c   Jacobsson, Bo ^d,e  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY OF PARDUBICE   (Czech Republic)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Histological chorioamnionitis; Microbial invasion of the amniotic cavity; Pattern recognition receptor; Soluble receptor

Indexed keywords

TOLL LIKE RECEPTOR 2;

ADULT; AMNIOCENTESIS; AMNION; AMNION FLUID ANALYSIS; ARTICLE; CHORIOAMNIONITIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MICROBIAL COLONIZATION; PREDICTIVE VALUE; PREGNANCY; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; AMNIOCENTESIS; AMNION; AMNIOTIC FLUID; CHORIOAMNIONITIS; COHORT STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; PREGNANCY; PROSPECTIVE STUDIES; REFERENCE VALUES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SOLUBILITY; TOLL-LIKE RECEPTOR 2;

EID: 84874081497     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.741634     Document Type: Article

References (41)

1. Kacerovsky M, Musilova I, Khatibi A, Skogstrand K, Hougaard DM, Tambor V, Tosner J, Jacobsson B. Intraamniotic inflammatory response to bacteria: analysis of multiple amniotic fluid proteins in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2012;25:2014-2019.
2. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178-193.
3. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-1507.
4. Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokström H, Holst RM, Nikolaitchouk N, Wennerholm UB, Hagberg H. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand 2003;82:423-431.
5. Romero R, Quintero R, Oyarzun E, Wu YK, Sabo V, Mazor M, Hobbins JC. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;159:661-666.
6. Menon R, Taylor RN, Fortunato SJ. Chorioamnionitis-A complex pathophysiologic syndrome. Placenta 2010;31:113-120.
7. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 2010;87:989-999.
8. Oliveira-Nascimento L, Massari P, Wetzler LM. The role of TLR2 in infection and immunity. Front Immunol 2012;3:79.
9. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009;21:317-337.
10. Raby AC, Le Bouder E, Colmont C, Davies J, Richards P, Coles B, George CH, et al. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol 2009;183:506-517.
11. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006;117:979-87; quiz 988.
12. Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu Rev Biochem 2007;76:141-165.
13. Beutler BA. TLRs and innate immunity. Blood 2009;113:1399-1407.
14. Zähringer U, Lindner B, Inamura S, Heine H, Alexander C. TLR2 -promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008;213:205-224.
15. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of Tolllike receptor-mediated immune responses. Nat Rev Immunol 2005;5:446-458.
16. Kuroishi T, Tanaka Y, Sakai A, Sugawara Y, Komine K, Sugawara S. Human parotid saliva contains soluble Toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol 2007;44:1969-1976.
17. O'Neill LA. When signaling pathways collide: positive and negative regulation of Toll-like receptor signal transduction. Immunity 2008;29:12-20.
18. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, Griffin GE, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003;171:6680-6689.
19. Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, Aukrust P, et al. Soluble Toll-like receptor 2 in HIV infection: association with disease progression. AIDS 2004;18:2437-2439.
20. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, et al. Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. J Card Fail 2006;12:659-663.
21. Srinivasan M, Kodumudi KN, Zunt SL. Soluble CD14 and Toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin Immunol 2008;126:31-37.
22. Yang HB, Xie KQ, Deng JM, Qin SM. Expression of soluble Toll-like receptors in pleural effusions. Chin Med J 2010;123:2225-2230.
23. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S, Buhimschi IA. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol 2009;182:7244-7253.
24. Kacerovsky M, Andrys C, Drahosova M, Musilova I, Hornychova H, Lesko D, Tosner J, Jacobsson B. Soluble Toll-like receptor 1 family members in the amniotic fluid of women with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med 2012;25:1699-1704.
25. The Czech Society of Obstetrics and Gynecology. Clinical Guidelines in Obstetrics; 2007. Available at: http://www.perinatologie.cz/dokumenty/
26. Kacerovsky M, Pliskova L, Bolehovska R, Musilova I, Hornychova H, Tambor V, Jacobsson B. The microbial load with genital mycoplasmas correlates with the degree of histologic chorioamnionitis in preterm PROM. Am J Obstet Gynecol 2011;205:213.e1-213.e7.
27. Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 1989;73:383-389.
28. Hayati AR, Mohamed AE, Tan GC. An immunohistochemical study of Toll-like receptors 2 and 4 in placenta with and without infection. Malays J Pathol 2010;32:13-19.
29. Kacerovsky M, Pliskova L, Bolehovska R, Skogstrand K, Hougaard DM, Tsiartas P, Jacobsson B. The impact of the microbial load of genital mycoplasmas and gestational age on the intensity of intraamniotic inflammation. Am J Obstet Gynecol 2012;206:342.e1-342.e8.
30. Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, Kuivaniemi H, Tromp G, et al. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004;191:1346-1355.
31. Rindsjö E, Holmlund U, Sverremark-Ekström E, Papadogiannakis N, Scheynius A. Toll-like receptor-2 expression in normal and pathologic human placenta. Hum Pathol 2007;38:468-473.
32. Roberts DJ, Celi AC, Riley LE, Onderdonk AB, Boyd TK, Johnson LC, Lieberman E. Acute histologic chorioamnionitis at term: nearly always noninfectious. PLoS ONE 2012;7:e31819.
33. Onderdonk AB, Delaney ML, DuBois AM, Allred EN, Leviton A; Extremely Low Gestational Age Newborns (ELGAN) Study Investigators. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol 2008;198:110.e1-110.e7.
34. Lau J, Magee F, Qiu Z, Houbé J, Von Dadelszen P, Lee SK. Chorioamnionitis with a fetal inflammatory response is associated with higher neonatal mortality, morbidity, and resource use than chorioamnionitis displaying a maternal inflammatory response only. Am J Obstet Gynecol 2005;193:708-713.
35. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, Jun JK. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000;183:1124-1129.
36. Basu S, Fenton MJ. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 2004;286:L887-L892.
37. Chaudhuri N, Whyte MK, Sabroe I. Reducing the Toll of inflammatory lung disease. Chest 2007;131:1550-1556.
38. Raymond T, Schaller M, Hogaboam CM, Lukacs NW, Rochford R, Kunkel SL. Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation. Proc Am Thorac Soc 2007;4:635-641.
39. Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA. Evidence for an innate immune response in the immature human intestine: Tolllike receptors on fetal enterocytes. Pediatr Res 2001;49:589-593.
40. Petrikin JE, Gaedigk R, Leeder JS, Truog WE. Selective Toll-like receptor expression in human fetal lung. Pediatr Res 2010;68:335-338.
41. Been JV, Zimmermann LJ. Histological chorioamnionitis and respiratory outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F218-F225.